284 related articles for article (PubMed ID: 34873015)
41. Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.
Hida A; Yamashita T; Hosono Y; Inoue M; Kaida K; Kadoya M; Miwa Y; Yajima N; Maezawa R; Arai S; Kurasawa K; Ito K; Shimada H; Iwanami T; Sonoo M; Hatanaka Y; Murayama S; Uchibori A; Chiba A; Aizawa H; Momoo T; Nakae Y; Sakurai Y; Shiio Y; Hashida H; Yoshizawa T; Sakiyama Y; Oda A; Inoue K; Takeuchi S; Iwata NK; Date H; Masuda N; Mikata T; Motoyoshi Y; Uesaka Y; Maeda MH; Nakashima R; Tsuji S; Kwak S; Mimori T; Shimizu J
Neurology; 2016 Jul; 87(3):299-308. PubMed ID: 27343066
[TBL] [Abstract][Full Text] [Related]
42. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
He L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
[TBL] [Abstract][Full Text] [Related]
43. [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].
Takahashi Y; Takamiya M; Ichimura Y; Okiyama N; Nishino I; Morimoto N
Rinsho Shinkeigaku; 2023 Nov; 63(11):737-742. PubMed ID: 37880118
[TBL] [Abstract][Full Text] [Related]
44. [Diagnosis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis led by sarcoplasmic myxovirus resistance protein A expression on muscle pathology].
Iwami K; Kano T; Mizushima K; Yaguchi H; Nishino I; Houzen H
Rinsho Shinkeigaku; 2024 Jun; ():. PubMed ID: 38897972
[TBL] [Abstract][Full Text] [Related]
45. Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
Wolstencroft PW; Casciola-Rosen L; Fiorentino DF
JAMA Dermatol; 2018 Oct; 154(10):1199-1203. PubMed ID: 30140893
[TBL] [Abstract][Full Text] [Related]
46. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression.
Allenbach Y; Leroux G; Suárez-Calvet X; Preusse C; Gallardo E; Hervier B; Rigolet A; Hie M; Pehl D; Limal N; Hufnagl P; Zerbe N; Meyer A; Aouizerate J; Uzunhan Y; Maisonobe T; Goebel HH; Benveniste O; Stenzel W;
Am J Pathol; 2016 Mar; 186(3):691-700. PubMed ID: 26806087
[TBL] [Abstract][Full Text] [Related]
47. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
Demortier J; Vautier M; Chosidow O; Gallay L; Bessis D; Berezne A; Cordel N; Schmidt J; Smail A; Duffau P; Jachiet M; Begon E; Gottlieb J; Chasset F; Graveleau J; Marque M; Cesbron E; Forestier A; Josse S; Kluger N; Beauchêne C; Le Corre Y; Pagis V; Rigolet A; Guillaume-Jugnot P; Authier FJ; Guilain N; Streichenberger N; Leonard-Louis S; Boussouar S; Landon-Cardinal O; Benveniste O; Allenbach Y
Rheumatology (Oxford); 2023 Dec; 62(12):3932-3939. PubMed ID: 37010495
[TBL] [Abstract][Full Text] [Related]
48. Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.
Cerbelli B; Pisano A; Colafrancesco S; Pignataro MG; Biffoni M; Berni S; De Luca A; Riccieri V; Priori R; Valesini G; d'Amati G; Giordano C
Virchows Arch; 2018 Mar; 472(3):477-487. PubMed ID: 29147923
[TBL] [Abstract][Full Text] [Related]
49. Cancer associated autoantibodies in idiopathic inflammatory myopathies: A retrospective cohort from a single center in China.
Zhao Y; Su H; Yin X; Hou H; Wang Y; Xu Y; Li X; Zhang N; Sun W; Wei W
Med Clin (Barc); 2023 Jan; 160(1):10-16. PubMed ID: 35842306
[TBL] [Abstract][Full Text] [Related]
50. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
[TBL] [Abstract][Full Text] [Related]
51. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
52. Research progress on the dermatomyositis specific autoantibodies and malignancy associated dermatomyositis.
Xu Y; Yang Y; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1890-1898. PubMed ID: 38448383
[TBL] [Abstract][Full Text] [Related]
53. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
[TBL] [Abstract][Full Text] [Related]
54. Mitochondrial morphology and MAVS-IFN1 signaling pathway in muscles of anti-MDA5 dermatomyositis.
Jiang Y; Liu Y; Zhao Y; Zheng Y; Yu M; Deng J; Hao H; Zhang W; Wang Z; Yuan Y
Ann Clin Transl Neurol; 2021 Mar; 8(3):677-686. PubMed ID: 33576578
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
[TBL] [Abstract][Full Text] [Related]
56. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
57. C4d staining as immunohistochemical marker in inflammatory myopathies.
Pytel P
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):696-704. PubMed ID: 24897075
[TBL] [Abstract][Full Text] [Related]
58. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
60. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
